These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 17289889

  • 1. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
    Zhang C, Li Z, Cheng Y, Jia F, Li R, Wu M, Li K, Wei L.
    Clin Cancer Res; 2007 Feb 01; 13(3):944-52. PubMed ID: 17289889
    [Abstract] [Full Text] [Related]

  • 2. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
    Liu WJ, Wang L, Wang JP, Li JQ, Zhang CQ, Zheng L, Yuan YF.
    Ai Zheng; 2006 Jun 01; 25(6):696-700. PubMed ID: 16764763
    [Abstract] [Full Text] [Related]

  • 3. Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma.
    Cheng Y, Zhang C, Zhao J, Wang C, Xu Y, Han Z, Jiang G, Guo X, Li R, Bu X, Wu M, Wei L.
    Exp Mol Pathol; 2010 Feb 01; 88(1):112-7. PubMed ID: 19879258
    [Abstract] [Full Text] [Related]

  • 4. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
    Li B, Liu W, Wang L, Li M, Wang J, Huang L, Huang P, Yuan Y.
    Ann Surg Oncol; 2010 Jul 01; 17(7):1917-26. PubMed ID: 20112070
    [Abstract] [Full Text] [Related]

  • 5. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM.
    Mol Carcinog; 2002 Oct 01; 35(2):85-92. PubMed ID: 12325038
    [Abstract] [Full Text] [Related]

  • 6. CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma.
    Zhang C, Guo X, Jiang G, Zhang L, Yang Y, Shen F, Wu M, Wei L.
    Int J Cancer; 2008 Sep 01; 123(5):998-1004. PubMed ID: 18546260
    [Abstract] [Full Text] [Related]

  • 7. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
    Chang MS, Uozaki H, Chong JM, Ushiku T, Sakuma K, Ishikawa S, Hino R, Barua RR, Iwasaki Y, Arai K, Fujii H, Nagai H, Fukayama M.
    Clin Cancer Res; 2006 May 15; 12(10):2995-3002. PubMed ID: 16707594
    [Abstract] [Full Text] [Related]

  • 8. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
    Oue N, Mitani Y, Motoshita J, Matsumura S, Yoshida K, Kuniyasu H, Nakayama H, Yasui W.
    Cancer; 2006 Mar 15; 106(6):1250-9. PubMed ID: 16475210
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer.
    Liu Z, Zhao J, Chen XF, Li W, Liu R, Lei Z, Liu X, Peng X, Xu K, Chen J, Liu H, Zhou QH, Zhang HT.
    Lung Cancer; 2008 Oct 15; 62(1):15-22. PubMed ID: 18358560
    [Abstract] [Full Text] [Related]

  • 11. Status and significance of CpG island methylator phenotype in endometrial cancer.
    Zhang QY, Yi DQ, Zhou L, Zhang DH, Zhou TM.
    Gynecol Obstet Invest; 2011 Oct 15; 72(3):183-91. PubMed ID: 21968189
    [Abstract] [Full Text] [Related]

  • 12. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y.
    Clin Cancer Res; 2008 Nov 15; 14(22):7405-12. PubMed ID: 19010857
    [Abstract] [Full Text] [Related]

  • 13. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.
    Ko E, Kim Y, Kim SJ, Joh JW, Song S, Park CK, Park J, Kim DH.
    Cancer Epidemiol Biomarkers Prev; 2008 Sep 15; 17(9):2260-7. PubMed ID: 18723830
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
    Roncalli M, Bianchi P, Bruni B, Laghi L, Destro A, Di Gioia S, Gennari L, Tommasini M, Malesci A, Coggi G.
    Hepatology; 2002 Aug 15; 36(2):427-32. PubMed ID: 12143052
    [Abstract] [Full Text] [Related]

  • 16. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.
    Lin JC, Wu YC, Wu CC, Shih PY, Wang WY, Chien YC.
    Ann Hepatol; 2015 Aug 15; 14(4):494-504. PubMed ID: 26019036
    [Abstract] [Full Text] [Related]

  • 17. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z.
    Zhonghua Zhong Liu Za Zhi; 2008 Nov 15; 30(11):831-6. PubMed ID: 19173828
    [Abstract] [Full Text] [Related]

  • 18. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY, Hsieh SY, Lu YJ, Wu CS, Chen LC, Lo SJ, Wu CT, Chou MY, Huang TH, Chang YS.
    Genes Chromosomes Cancer; 2009 Dec 15; 48(12):1057-68. PubMed ID: 19760608
    [Abstract] [Full Text] [Related]

  • 19. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W, Yao DF, Yuan YM, Fan JW, Lu XF, Li XH, Qiu LW, Zong L, Wu XH.
    Hepatobiliary Pancreat Dis Int; 2006 Nov 15; 5(4):538-44. PubMed ID: 17085339
    [Abstract] [Full Text] [Related]

  • 20. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma.
    Schagdarsurengin U, Wilkens L, Steinemann D, Flemming P, Kreipe HH, Pfeifer GP, Schlegelberger B, Dammann R.
    Oncogene; 2003 Mar 27; 22(12):1866-71. PubMed ID: 12660822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.